Koninklijke DSM NV Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 3/26/2022)
| Balance Sheet | Total Assets | 17,403,000,000.00 | ROE | – |
| Balance Sheet | Total Equity | 10,845,000,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -433,000,000.00 | P/FCF | – |
| Cashflow | Free Cash Flow | 994,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 1,427,000,000.00 | P/CF | – |
| Income | Earnings per Share (diluted) | 9.77 | Div. Yield | – |
| Income | Net Income | 1,700,000,000.00 | P/E | – |
| Income | Shares Outstanding | 172,000,000.00 | P/B | – |
| Income | Total Revenue | 8,390,000,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Koninklijke DSM N.V., a science-based company, engages in health, nutrition, and materials businesses worldwide. The company operates through three segments: Nutrition, Materials, and Innovation Center. The Nutrition segment offers nutrients, such as vitamins, carotenoids, nutritional lipids, and other ingredients to feed, food, pharmaceutical, and personal care industries; and food enzymes, cultures, yeast extracts, savory flavors, hydrocolloids, and other specialty ingredients for use in dairy, baking, beverage, and savory applications. The Materials segment provides Dyneema, a fiber solution serving textiles, commercial marine, and sports segments; high-performance plastics primarily for use in automotive and electronics markets, as well as offers solutions to specialized industries, including water management, breathable textiles, and flexible food packaging; and resins solutions for paints and coatings, fiber optic coatings, and 3D printing applications. The Innovation Center segment offers cellulosic bio-ethanol and bio-based succinic acids; anti-reflective coatings for solar glass; and anti-soiling coatings for use in cleaning and maintaining solar farms in desert-like conditions. This segment also produces biomedical materials and technologies that enable medical device manufacturers to enhance care across various medical specialties. Koninklijke DSM N.V. was founded in 1902 and is headquartered in Heerlen, the Netherlands.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.dsm.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more